Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Aquacel Hypersensitivity Dressing in TJAs

NCT: NCT06011629 · COMPLETED

NCT IDNCT06011629
StatusCOMPLETED
Start Date2023-06-18
Completion2025-06-03
SponsorRush University Medical Center (OTHER)
First posted
Last updated

Brief Summary

The aim of this multi-surgeon, single institution study is to prospectively evaluate the incidence of allergic contact dermatitis (ACD) following application of AQUACEL Ag, a silver-containing hydrofiber dressing, in total hip and knee arthroplasty patients. Arthroplasty-naïve patients will be compared to prior total joint arthroplasty patients who received a Aquacel dressing postoperatively.

Frequently Asked Questions

What is Aquacel Hypersensitivity Dressing in TJAs?

Aquacel Hypersensitivity Dressing in TJAs is a clinical trial registered under NCT06011629. Current status: COMPLETED.

What is the status of NCT06011629?

The current status of NCT06011629 (Aquacel Hypersensitivity Dressing in TJAs) is: COMPLETED.

When did Aquacel Hypersensitivity Dressing in TJAs start?

Aquacel Hypersensitivity Dressing in TJAs started on 2023-06-18.

Related Devices

K173675AQUACEL Ag+ EXTRA Enhanced Hydrofiber Dressing with Silver and Strengthening FiberConvatec Limited K191998Mako Total Hip Application, Mako Total Knee ApplicationMako Surgical Corp.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑